Solid state examination of a gliclazide:beta-cyclodextrin complex

European Journal of Pharmaceutical Sciences

Volumn 5, Issue 4, 1997, Pages 209-214

  Winters, Conrad S ^a   York, Peter ^a   Timmins, Peter ^b  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

Beta cyclodextrin; Complexation; Gliclazide; Solid state complex

Indexed keywords

BETA CYCLODEXTRIN; GLICLAZIDE; SULFONYLUREA;

ARTICLE; CHEMICAL STRUCTURE; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRECIPITATION; PRIORITY JOURNAL; SOLID STATE; STOICHIOMETRY; THERMOGRAVIMETRY; X RAY DIFFRACTION;

EID: 0030919347     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(97)00275-3     Document Type: Article

References (11)

1. Ford, J.L. and Timmins, P. (1989) Pharmaceutical Thermal Analysis - Techniques and Applications, Ellis Horwood, Chichester, UK.
2. 13C-N.M.R. Investigations of anhydrous and hydrated cyclomalto-oligosaccharides. The role of water hydration. Carbohydr. Res. 166, 27-34.
3. Gandhi, R.B. and Karara, A.H. (1988) Characterization, dissolution and diffusion properties of tolbutamide-cyclodextrin complex system. Drug Dev. Ind. Pharm. 14(5), 657-682.
4. Kobayashi K., Kimura M., Sakoguchi T., Kitani Y., Hata M. and Matsuoka A. (1981) Influence of blood proteins on biomedical analysis. III. Pharmacokineteics and protein binding of gliclazide. J. Pharmacobiodyn. 4, 436-442.
5. Kurozumi, M., Nambu, N. and Nagai, T. (1975) Inclusion compounds of non steroidal antiinflammatory and other slightly water soluble drugs with α and β cyclodextrins in powdered form. Chem. Pharm. Bull. 23, 3062-3068.
6. Nishioka, F., Nakanishi, I., Fujiwara, T. and Tomita, K. (1984) The crystal and molecular structure of the beta-cyclodextrin inclusion complex with aspirin and salicylic acid. J. Inclusion Phenom. 2(3-4), 701-714.
7. Reddy, R.K., Khalil, S.A., and Gouda, M.W. (1976) Dissolution characteristics and oral absorption of digitoxin and digoxin coprecipitates. J. Pharm. Sci. 65, 1753-1758.
8. Shiba, T., Kajinuma, H., Suzuki, K., Hagura, R., Kawai, A., Katagiri, H., Sardo, H., Shirakawa, W., Kasaka, K. and Kuzuya, N. (1986) Serum gliclazide concentration in diabetic patients. Relationship between gliclazide dose and serum concentration. Diabetes Res. Clin. Pract. 2, 301-306.
9. Winters, C.S., York, P. and Timmins, P. (1991) The formation of solid state inclusion complexes of gliclazide with a range of cyclodextrins. Pharm. Res. 8(10 Suppl.) Oct., S104.
10. Winters, C.S., Shields, L., York, P. and Timmins, P. (1994) Solid state properties and crystal structure of gliclazide. J. Pharm. Sci. 83(3), 300-304.
11. Winters, C.S., York, P. and Timmins, P. (1997) Role of molecular modelling in understanding the hydrolytic degradation of a gliclazide:beta-cyclodextrin complex, Eur. J. Pharm. Sci. submitted.